311 studies found for:    Endometrial Cancer: Clinical Trials
Show Display Options
RSS Create an RSS feed from your search for:
Endometrial Cancer: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
Conditions: Recurrent Cervical Cancer;   Recurrent Endometrial Carcinoma;   Recurrent Uterine Sarcoma;   Stage I Endometrial Carcinoma;   Stage I Uterine Sarcoma;   Stage IA Cervical Cancer;   Stage IB Cervical Cancer;   Stage II Endometrial Carcinoma;   Stage II Uterine Sarcoma;   Stage IIA Cervical Cancer;   Stage IIB Cervical Cancer;   Stage III Cervical Cancer;   Stage III Endometrial Carcinoma;   Stage III Uterine Sarcoma;   Stage IV Endometrial Carcinoma;   Stage IV Uterine Sarcoma;   Stage IVA Cervical Cancer;   Stage IVB Cervical Cancer
Interventions: Other: medical chart review;   Other: questionnaire administration
2 Active, not recruiting Phase I/IIa Trial of Folate Binding Protein Vaccine in Ovarian Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer;   Fallopian Cancer;   Peritoneal Cancer
Interventions: Biological: E39 peptide vaccine;   Other: Clinical tracking for disease progression/recurrence
3 Active, not recruiting A Phase II Trial of Adjuvant Radiotherapy Combined With Chemotherapy for Patients With High-risk Endometrial Cancer
Condition: Prosthesis Survival
Interventions: Radiation: radiotherapy;   Drug: Cisplatin;   Drug: Cisplatin and Doxorubicin and Cyclophosphamide;   Drug: Paclitaxel and Carboplatin
4 Completed Radiation Therapy or Observation Only in Treating Patients With Endometrial Cancer Who Have Undergone Surgery
Condition: Endometrial Cancer
Intervention: Radiation: radiation therapy
5 Recruiting Trial Between Two Follow up Regimens With Different Test Intensity in Endometrial Cancer Treated Patients
Condition: Endometrial Cancer
Interventions: Procedure: Intensive/Low-Risk Treatment (IA G1; IA G2);   Procedure: Intensive/High-Risk Treatment (≥ IA G3);   Procedure: Minimalist/Low-Risk Treatment (IA G1; IA G2);   Procedure: Minimalist/High-Risk Treatment (≥ IA G3)
6 Active, not recruiting Randomized Trial of Radiation Therapy With or Without Chemotherapy for Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Radiation: Radiation Therapy;   Drug: cisplatin;   Drug: carboplatin;   Drug: Paclitaxel
7 Recruiting Prospective Randomised Phase II Trial Evaluating Adjuvant Pelvic Radiotherapy Using Either IMRT or 3-Dimensional Planning for Endometrial Cancer. ICORG 09-06
Conditions: Endometrial Cancer;   Gastrointestinal Complications;   Radiation Toxicity;   Urinary Complications
Intervention: Radiation: 45 Gy/25 fractions
8 Completed Clinical Trial of Ridaforolimus Compared to Progestin or Chemotherapy for Advanced Endometrial Carcinoma (MK-8669-007 AM6)
Condition: Endometrial Cancer
Interventions: Drug: ridaforolimus;   Drug: medroxyprogesterone acetate tablets OR megestrol acetate;   Drug: chemotherapy
9 Completed Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer
Condition: Endometrial Carcinoma
Intervention: Drug: carboplatin, paclitaxel, and bevacizumab
10 Completed Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: brachytherapy;   Radiation: radiation therapy
11 Not yet recruiting Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer
Conditions: Ovarian Cancer;   Endometrial Cancer
Intervention: Drug: everolimus and letrozole
12 Completed Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the Uterus
Conditions: Endometrial Cancer;   Sarcoma
Interventions: Procedure: conventional surgery;   Procedure: laparoscopic surgery
13 Recruiting Carboplatin-Paclitaxel ± Bevacizumab in Advanced (Stage III-IV) or Recurrent Endometrial Cancer
Condition: Stage III-IV or Recurrent Endometrial Cancer
Interventions: Drug: Bevacizumab;   Drug: Carboplatin AUC 5+Paclitaxel 175 mg/mq q 21 for 6-8 cycles
14 Not yet recruiting A Parp Inhibitor (BMN 673) for Inoperable Advanced eNDometrial cAncer
Condition: Endometrial Cancer
Intervention: Drug: BMN 673
15 Completed Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer
Conditions: Endometrial Adenocarcinoma;   Endometrial Adenosquamous Cell Carcinoma;   Endometrial Clear Cell Carcinoma;   Endometrial Papillary Serous Carcinoma;   Recurrent Endometrial Carcinoma;   Stage IIIA Endometrial Carcinoma;   Stage IIIB Endometrial Carcinoma;   Stage IIIC Endometrial Carcinoma;   Stage IVA Endometrial Carcinoma;   Stage IVB Endometrial Carcinoma
Interventions: Drug: temsirolimus;   Other: laboratory biomarker analysis
16 Terminated Clinical Trial of PM00104 (Zalypsis®) in Patients With Advanced and/or Metastatic Endometrial or Cervical Cancer Previously Treated With One Line of Systemic Chemotherapy
Conditions: Uterine Cervical Cancer;   Endometrial Cancer
Intervention: Drug: Zalypsis ( PM00104)
17 Active, not recruiting Temsirolimus With or Without Megestrol and Tamoxifen in Treating Patients With Advanced, Persistent, or Recurrent Endometrial Cancer
Conditions: Recurrent Endometrial Carcinoma;   Stage III Endometrial Carcinoma;   Stage IV Endometrial Carcinoma
Interventions: Drug: megestrol acetate;   Drug: tamoxifen citrate;   Drug: temsirolimus;   Other: laboratory biomarker analysis
18 Unknown  External-Beam Radiation Therapy or Implant Radiation Therapy Compared With Observation in Treating Patients Who Have Undergone Surgery for Stage I Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Other: clinical observation;   Procedure: adjuvant therapy;   Radiation: brachytherapy;   Radiation: radiation therapy
19 Completed POEM STUDY: A Phase IIa Trial in Endometrial Carcinoma With Temsirolimus
Conditions: Carcinoma, Endometrioid;   mTOR Protein
Intervention: Drug: Temsirolimus
20 Active, not recruiting PIK3CA Mutation Stratified Trial of MK-2206 in Recurrent or Advanced Endometrial Cancer
Condition: Endometrial Cancer
Intervention: Drug: MK-2206

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years